Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004
Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway Source: Eur Respir J 2011; 37: 1237-1247 Year: 2011
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2005; 25: 494-501 Year: 2005
In vitro model to study the correlation between neutrophils and miR21 expression: a role in Bronchiolitis obliterans syndrome Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019
Balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the development of bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 327s Year: 2003
Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Source: Eur Respir J 2008; 32: 670-677 Year: 2008
Genetic polymorphism in the MMP7 gene correlates with the development of bronchiolitis obliterans syndrome Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options Year: 2009
Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation Source: Eur Respir J 2014; 43: 221-232 Year: 2004
Immunohistochemical characterization of inflammatory cells in childhood bronchiolitis obliterans Source: Eur Respir J 2001; 18: Suppl. 33, 292s Year: 2001
Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet? Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55 Year: 2004
Mediators produced by apoptotic endothelial cells activates Twist and Snail; role in bronchiolitis obliterans Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010
Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19 Year: 2004
Calprotectin as new sensitive marker of neutrophilic inflammation in patients with bronchiolitis obliterans Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
Bronchiolitis obliterans (BO) treatment with collagen with collagen type V and corticoid by nasal-drop in Balb-c mice (BM) Source: Eur Respir J 2005; 26: Suppl. 49, 732s Year: 2005
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004
Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9 Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006
The role of cytomegalovirus in the development of bronchiolitis obliterans syndrome Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015
The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis Source: Eur Respir J, 57 (3) 2000344; 10.1183/13993003.00344-2020 Year: 2021
Putting the spotlight on macrophage-derived cathepsin in the pathophysiology of obliterative bronchiolitis Source: Eur Respir J, 57 (5) 2004607; 10.1183/13993003.04607-2020 Year: 2021